Waterborne outbreak of Mycobacterium abscessus in a UK specialist heart and lung hospital 2019-2026: patients, mitigations and implications

🔁 Repost
🔗 https://t.co/tJ7tNst1AH

Antimicrobials in a Box: A Primer on the Risks of Direct-to-Consumer Antimicrobial Preparedness Kits

🔁 Repost
🔗 https://bit.ly/4iRNtOi

Excess Hospital Use and Years of Life Lost After Cancer Diagnosis among People with HIV: A Nationwide Study in Spain

✅ Just Accepted
🔗 https://bit.ly/4s1YKOB

Antibiotic exposure and the emergence of multidrug resistant bacteria in patients with liver cirrhosis: A prospective cohort study

✅ Just Accepted
🔗 https://bit.ly/4j9YlqW

Shorter Antibiotic Duration for Pseudomonas Bacteremia: A Call for Future Trials

✅ Just Accepted
https://bit.ly/4yKKBYL

Tipping the Scales: More Reasons to Re-evaluate Antibiotic Use in Patients with Advanced Liver Disease

✅ Just Accepted
🔗 https://bit.ly/4zw7j6V

Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024–2025

🔁 Repost
🔗 https://t.co/EMSWOEkMy7

Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty

✅ Just Accepted
🔗 https://bit.ly/4yFEa90

Does the DOOR Account for Post-randomization Treatment Modification or Incorporate It?

✅ Just Accepted
🔗 https://bit.ly/4rSzhH4

Treatment Timing May Challenge the Apparent Benefit of Intrathecal Therapy in Tuberculous Meningitis

✅ Just Accepted
🔗 https://bit.ly/4rVwCN3

Atypical Clostridioides difficile Infection: Defining a Mortality-Associated Dysmotility Phenotype

🔁 Repost
🔗 https://t.co/UMNbu7yBoU

On IDSA’s & HIVMA’s Science Speaks: Learn more about the efficacy of switching to doravirine/islatravir, how immunocompromised individuals hospitalized with COVID-19 remain at increased mortality risk and other research in @jidjournal.bsky.social to inform clinical practice. https://bit.ly/4AYYFzi

The 2026 Guidance of the Infectious Diseases Society of America on the Treatment of Antimicrobial-Resistant Gram-Negative Infections and the Roadmap to European Implementation

🔁 Repost
🔗 https://t.co/w6aPYQ7daU

Enterococcal Bacteremia: A Day-4 Decision Requires Day-4 Eligibility

🔁 Repost
🔗 https://bit.ly/4xLSUlu

Interpreting Noninferiority in Risk-Stratified HIV Follow-up: Beyond a Single Margin

✅ Just Accepted
🔗 https://bit.ly/4y7YSxw

Interpreting Post Hoc Noninferiority Analyses in Reduced-Frequency HIV Follow Up

✅ Just Accepted
🔗 https://bit.ly/4rQIMH0

A Puzzle is More than One Piece: The Clean Margin in Diabetic Foot Osteomyelitis

🔁 Repost
🔗 https://t.co/TYzctUGpuZ

Relationship between Antibiotic Prescription and Survival in Hospice

🔁 Repost
⭐ Editor's Choice
🔗 https://t.co/seJhD5GDma

Time to Antibiotics or Time to Effective Antimicrobial Therapy?

🔁 Repost
🔗 https://t.co/uZdhB1ILN7

Initial Carbapenem Choice Versus Sustained Single-Group Therapy in the Albumin-Carbapenem Interaction

🔁 Repost
🔗 https://t.co/Zas0YSNOAs